203 related articles for article (PubMed ID: 36986234)
1. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data.
Lee J; Jo G; Park D; Jun HJ; Bae JH; Shin MJ
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986234
[TBL] [Abstract][Full Text] [Related]
2. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
Kim D; Kim WR; Kim HJ; Therneau TM
Hepatology; 2013 Apr; 57(4):1357-65. PubMed ID: 23175136
[TBL] [Abstract][Full Text] [Related]
3. Association of liver fibrosis biomarkers with overall and CVD mortality in the Korean population: The Dong-gu study.
Choi SW; Kweon SS; Lee YH; Ryu SY; Nam HS; Shin MH
PLoS One; 2022; 17(12):e0277729. PubMed ID: 36512564
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.
Seo YG; Polyzos SA; Park KH; Mantzoros CS
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3322-3335. PubMed ID: 37164111
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Kang MK; Kim MC
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837575
[No Abstract] [Full Text] [Related]
6. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis.
Yan Z; Liu Y; Li W; Zhao X; Lin W; Zhang J; Yu S; Ma J; Wang J; Yu P; Li W; Liu X
Eur J Clin Invest; 2022 Nov; 52(11):e13855. PubMed ID: 36001034
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
[TBL] [Abstract][Full Text] [Related]
9. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
[TBL] [Abstract][Full Text] [Related]
10. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
Hydes TJ; Kennedy OJ; Buchanan R; Cuthbertson DJ; Parkes J; Fraser SDS; Roderick P
BMC Med; 2023 May; 21(1):185. PubMed ID: 37198624
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
Kim MJ; Lee KJ
BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
[TBL] [Abstract][Full Text] [Related]
13. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300
[TBL] [Abstract][Full Text] [Related]
14. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
16. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.
Wang T; Xi Y; Raji A; Crutchlow M; Fernandes G; Engel SS; Zhang X
Ann Hepatol; 2024; 29(1):101154. PubMed ID: 37742743
[TBL] [Abstract][Full Text] [Related]
17. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
18. Associations of different serum folate forms with indices of nonalcoholic fatty liver disease and advanced fibrosis.
Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
Obes Res Clin Pract; 2023; 17(1):58-65. PubMed ID: 36746711
[TBL] [Abstract][Full Text] [Related]
19. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
[TBL] [Abstract][Full Text] [Related]
20. Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese Adults.
Guo W; Zhao X; Cheng D; Liang X; Miao M; Li X; Lu J; Xu N; Hu S; Zhang Q
J Nutr Health Aging; 2023; 27(11):960-965. PubMed ID: 37997716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
